Background Type 1 diabetes mellitus is a T-cell–mediated autoimmune disease that leads
to a major loss of insulin-secreting beta cells. The further decline of beta-cell function after …

We investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific
antibodies and T-cell responses against SARS-CoV-2 and human coronavirus (HCoV) 229E …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

Objective: To investigate the safety and efficacy of rituximab (RTX) for systemic symptoms in
patients with primary Sjögren’s syndrome (pSS), and changes in B cell biomarkers. Patients …

Aims/hypothesis The aim of the study was to examine the 48 month outcome of treating
recent-onset type 1 diabetic patients for 6 days with humanised CD3-antibody, ChAglyCD3. …

Insulin-dependent or type 1 diabetes is a prototypic autoimmune disease whose incidence
steadily increased over the past decades in industrialized countries. Recent evidence …

Importance One-third of patients with rheumatoid arthritis show inadequate response to tumor
necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment exists. …

Microbial nucleic acid recognition serves as the major stimulus to an antiviral response,
implying a requirement to limit the misrepresentation of self nucleic acids as non-self and the …

Background and objectives: Standard treatment for lupus nephritis, including corticosteroids
and cyclophosphamide, is efficient but is still associated with refractory or relapsing disease, …

Erdheim–Chester disease (ECD) pathophysiology remains largely unknown. Its treatment is
not codified and usually disappointing. Interferon (IFN)-α therapy lacks efficacy for some life-…